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Abstract
OBJECTIVE: To investigate the optimal dosage ra-
tio of chlorogenic acid and gardenia glycosides in
treating the rates with fatty liver disease induced
by high-fat feed.
METHODS: A rat model of non-alcoholic fatty liver
disease (NAFLD) was established by using a
high-fat diet. According to mathematical model
"uniform design", varying doses of chlorogenic acid
and gardenia glycosides have been combined to
form 6 medications for the treatment of NAFLD.
Samples were then taken to observe pathological
changes of the liver tissue (HE staining); changes in
the fat metabolism pathway e.g. triglyceride (TG)
and free fatty acid (FFA) content; alterations in liver
function, i.e. serum alanine aminotransferase (ALT)
and aspartate aminotransferase (AST) activity; and
differences in Malondialdehyde (MDA) and superox-
ide dismutase (SOD) content in the liver tissue. Mul-
tiple regression analysis was conducted to test the
optimal dosage ratio of chlorogenic acid and garde-
nia glycosides.
RESULTS: Fatty degeneration and vacuole-like
changes of different degrees occurred in hepatic
cells of the model group. Markers for fat metabo-
lism, serum ALT and AST activities, and expression
of MDA in liver tissue significantly increased, while
SOD decreased. Combination of 90 mg chlorogenic
acid and 90 mg Gardenia glycosides was the opti-
mal dosage ratio of chlorogenic acid and gardenia
glycosides in the treatment of rats with fatty liver
induced by high-fat diet.
CONCLUSION: Chlorogenic acid of 90 mg plus gar-
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denia glycosides of 90 mg was the best combina-
tion in the treatment of fatty liver disease in rats in-
duced by high-fat feed.
© 2016 JTCM. All rights reserved.
Key words: Chlorogenic acid; Gardenia glycosides;
Non-alcoholic fatty liver disease; Uniform design
method; Dose optimization
INTRODUCTION
It has been confirmed that Yinchenhao Decoction has
the efficacy of "clearing away heat and promoting di-
uresis, promoting blood circulation and removing
blood stasis" and has the significant pharmacological ef-
fect to anti fatty liver from clinical practice and basic re-
search.1 At the same time, we were using mathematical
model of "uniform design method" to optimize the
dosage ratio of Yinchenhao Decoction, and the result
showed that "3 g capillaris with 1.5 g Gardenia" was
the effective traditional Chinese medicine and optimal
dosage ratio in the Yinchenhao Decoction for anti
NAFLD.2 It is manifested that "uniform design" can
be a valid means to optimize the dosage ratio of com-
pound Traditional Chinese Medicine (TCM).3 With
the continuous development of TCM analysis technol-
ogy, the theory that the effective components of TCM
is the material base of TCM compound to exert phar-
macologic effects has been widely accepted.4 Studies
have shown that chlorogenic acid is the main effective
component in capillaries, has function to antibacterial
and cholagogic, to scaveng free radicals and antioxi-
dant pharmacological;5 while gardenia glycosides is the
main effective component in gardenia, with pharmaco-
logic effects of analgesic and anti-inflammatory, hepato-
protective and choleretic.6 Previous experimental re-
search found that the combination of chlorogenic acid
and gardenia glycosides has the similar effect to the
compatibility of Herba Artemisiae Scopariae and garde-
nia which can reduce fat content in HepG2 cells in-
duced by free fatty acid (FFA). It has been concluded
that combination of chlorogenic acid and gardenia gly-
cosides is the important material basis for treating fatty
liver disease, but the optimal dosage ratio still unclear.
This study aimed to investigate the optimal dosage ra-
tio of chlorogenic acid and gardenia glycosides in the
treatment of rates with fatty liver disease induced by
high-fat feed.
MATERIALS ANDMETHODS
Animals
Wistar male rats, sanitary degree, 4 weeks, weighing
(180 ± 10) g, were purchased from Shanghai Silaike Ex-
perimental Animals Co., Ltd. (Shanghai, China), li-
cense No. SCXK (Hu) 2008_0001. They were raised
in the experimental Animal Center of the Medical Col-
lege, Xiamen University (Xiamen, China). The use of
animals in this study was approved by the Ethics Com-
mittee of Xiamen University (protocol XMU-
LAC20120020).
Medicinals and reagents
The extracts of chlorogenic acid (Lot No.
ZL121115005) and gardenia glycosides (Lot No.
ZL12-12-06) were purchased from Zelang Pharmaceu-
tical Co., Ltd. (Nanjing, China). They were dissolved
in water. Both the decoction and the solution were
kept in refrigerator. Triglycerides (Cat No. 20131112),
free fatty acids (FFA) kit (lot No. 20140221), alanine
aminotransferase (ALT) kit (lot No. 20131020), aspar-
tate aminotransferase (AST) kit (lot No. 20131024),
oxide dismutase enzyme (SOD) and malondialdehyde
(MDA) were purchased from Beijing BHKT Clinical
Reagent Co., Ltd. (Beijing, China).
Animals model establishment and treatment
The models were induced with high fat feed (HFD),
which consisted of 83.25% basic feed, 10% lard, 1.5%
cholesterol, 0.2% sodium deoxycholate, 5% sugar,
0.05% prothio-pyrimidine; the control group was fed
with regular diet.
Uniform design "screening" experiment
According to Uniform design,3 U6(64) has been used to
arrange the different dose of chlorogenic acid and gar-
denia glycosides, X1 represent chlorogenic acid and X2
represent gardenia glycosides. For both these two effec-
tive components of Chinese herbal medicine, 6 levels
were used, from 15 to 90 mg (Table 1).
Uniform design "verification" experiment
According to the results of Uniform design "screening"
experiment, the group and its dosage were deter-
mined for Uniform design "verification" experiment.
The 50 rats were randomly divided into 5 groups: con-
trol group, the model group, optimal dose matched
group, chlorogenic acid group and gardenia glycosides
group, 10 in each group. 90 mg chlorogenic acid and
90 mg gardenia glycosides for 1 kg rats once day for
the optimal dose matched group, 90 mg chlorogenic
acid for 1 kg rats once day for Chlorogenic acid group
and 90 mg gardenia glycosides for 1 kg rats once day
for the Gardenia glycosides group. The rats in the opti-
mal dose matched group, the chlorogenic acid group
and gardenia glycosides group were intragastrically ad-
ministered the solution (1 mL/100 g body weight) re-
spectively for 4 weeks. Rats in the model group and
the control group were given drinking water (1 mL/
100 g body weight). After the last administration was
finished, the rats fasted for 12 h. Then they were
weighed and anesthetized with intraperitoneal injec-
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tion of 2% pentobarbital (3 mL/kg body weight). The
abdomen was cut open, and blood was taken from the
inferior vena cava and centrifuged at 4 ℃ for 15 min at
3000 r/min. The supernatant was taken and stored at
－80 ℃ . The liver was removed and two small pieces
in the same location of right lobe of the liver were tak-
en and placed into 10% neutral formaldehyde buffer
for fixation. Other liver tissues were further cut into
several parts, and kept in centrifuge tubes and stored at
－80℃.
Measured variables and methods
Hematoxylin and eosin (HE) staining were used to de-
termine pathological changes of hepatic tissue. After
HE staining, the degrees of lipid degeneration of liver
cells were observed under a light microscope.
Enzyme colorimetric analysis was used for the detec-
tion of triglyceride and FFA levels in the liver tissues.
Lai's method was used for the detection of serum ALT
and AST activity. Liver MDA and SOD activity has
been detected with ELISA.
Statistical analyses
All data were analyzed with SPSS 13.0 (SPSS Inc., Chi-
cago, IL, USA). The continuous data were expressed
with mean ± standard deviation ( xˉ ± s). One-way anal-
ysis of variance was performed to test the differences
between the groups. Multiple regression analysis was
performed for Uniform design "screening" experiment.
P < 0.05 was considered statistically significant.
RESULTS
Uniform design "screening" experiment
As shown in Table 2, HFD significantly increased tri-
glyceride by 4.2 folds when compared with regular fed
rats (P < 0.01). HFD increased FFA compared to the
rats in the control group (251 ± 36) vs (82 ± 12) μmol/
g prot (P < 0.01). Compared with the control group
(32.4 ± 6.2) and (34.3 ± 7.4) U/L, serum ALT and
Table 1 Uniform design "screening" experiment (mg·kg－1·
d－1)
Group
1
2
3
4
5
6
Chlorogenic
acid (X1)
15
30
45
60
75
90
Gardenia
glycosides (X2)
45
90
30
75
15
60
Dos-
age
60
120
75
135
90
150
Notes: of the seven groups subjected to high fat feed (HFD) for
8 weeks, one was randomly selected as the model group, 6
other groups selected as the uniform design experiment
group1-6 at the beginning of the fifth week. Group 1 was
treated with 15 mg·kg－1·d－1 Chlorogenic acid and 45 mg·kg－
1·d－1 Gardenia glycosides, Group 2 was treated with 30 mg·kg－
1·d－ 1 Chlorogenic acid and 90 mg·kg－ 1·d－ 1 Gardenia glyco-
sides, Group 3 was treated with 45 mg·kg－ 1·d－ 1 Chlorogenic
acid and 30 mg·kg－ 1·d－ 1 Gardenia glycosides, Group 4 was
treated with 60 mg·kg－1·d－1 Chlorogenic acid and 75 mg·kg－
1·d－1 Gardenia glycosides, Group 5 was treated with 75 mg·kg－
1·d－ 1 Chlorogenic acid and 15 mg·kg－ 1·d－ 1 Gardenia glyco-
sides, Group 6 was treated with 90 mg·kg－1·d－1 Chlorogenic ac-
id and 60mg·kg－1·d－1 Gardenia glycosides, all 6 groups were in-
tragastrically administered once a day for 4 weeks from the be-
ginning of the fifth week to the end of eighth week. The control
group and model group were intragastrically administered an
equal volume of drinking water at the same time.
Table 2 Comparison of related indexes of all groups ( xˉ ± s)
Group
Control
Model
1
2
3
4
5
6
n
7
7
7
7
7
7
7
7
TG
(mg/g)
12.4±3.2
50.9±9.8a
44.9±9.5
42.6±8.6
41.5±7.4
34.2±8.5
39.8±7.5
32.8±6.3
FFA
(μmol/g prot)
82.0±12.0
251.0±36.0a
204.0±32.0
222.0±39.0
216.0±31.0
200.0±35.0
168.0±31.0
137.0±20.0
ALT
(U/L)
32.4±6.2
86.6±20.3a
78.8±21.6
56.0±17.4
74.3±19.3
45.4±12.4
46.5±13.3
34.8±8.2
AST
(U/L)
34.3±7.4
89.2±21.4a
72.4±19.3
52.4±18.3
71.3±17.4
52.3±14.8
49.8±15.3
36.8±9.9
MDA
(nmol/mg prot)
9.8±2.7
18.3±6.7a
17.7±1.3
15.0±3.3
15.0±2.8
14.8±2.5
13.4±3.4
11.8±3.7
SOD
(U/mg prot)
40.22±6.3
19.23±3.9a
22.86±4.3
25.92±5.3
28.3±3.4
30.8±2.9
31.3±2.6
33.7±2.9
Notes: TG: Triglycerides; FFA: Free fatty acids; ALT: Serum alanine aminotransferase; AST: Aspartate aminotransferase; SOD: Oxide dis-
mutase enzyme; MDA: Alondialdehyde. Group 1 was treated with 15 mg·kg－1·d－1 Chlorogenic acid and 45 mg·kg－1·d－1Gardenia glyco-
sides, Group 2 was treated with 30 mg·kg－1·d－1 Chlorogenic acid and 90 mg·kg－1·d－1 Gardenia glycosides, Group 3 was treated with
45 mg·kg－1·d－1 Chlorogenic acid and 30 mg·kg－1·d－1Gardenia glycosides, Group 4 was treated with 60 mg·kg－1·d－1 Chlorogenic acid
and 75 mg·kg－1·d－1Gardenia glycosides, Group 5 was treated with 75 mg·kg－1·d－1 Chlorogenic acid and 15 mg·kg－1·d－1Gardenia gly-
cosides, Group 6 was treated with 90 mg·kg－1·d－1 Chlorogenic acid and 60 mg·kg－1·d－1Gardenia glycosides, all 6 groups were intragas-
trically administered once a day for 4 weeks from the beginning of the fifth week to the end of eighth week. The control group and model
group were intragastrically administered an equal volume of drinking water at the same time. The control group was fed with regular diet
and the model group induced by high fat feed (HFD), both of control group and model group were intragastrically administered an equal
volume of drinking water at the same time. Compared with the control group, aP < 0.01.
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AST activity in the model group significantly increased
(86.6 ± 20.3) and (89.3 ± 21.4) U/L (P < 0.01). For
liver MDA and SOD activity, HFD significantly in-
creased MDA, while decreased SOD activity in model
group (P < 0.01).
From Table 3, it can be concluded that the optimal
dose matched between the chlorogenic acid and garde-
nia glycosides. In order to inhibit the HFD on rats, the
optimal dose matched was 90 mg chlorogenic acid +
90 mg gardenia glycosides.
Uniform design "verification" experiment
Body weight and liver weight: FD increased body
weight compared to the rats in the control group (435
± 39) vs (332 ± 24) g, and increased liver weight by 2.1
folds compared to control group (17.5 ± 0.8) vs (8.4 ±
0.7) g, and increased fat weight compared to control
group (10.5 ± 1.3) vs (6.4 ± 0.5) g. The body weight
liver weight and fat weight were significantly lighter in
the optimal dose matched group, the chlorogenic acid
group and the gardenia glycosides group than those in
the model group (P < 0.05, P < 0.01; Table 4).
Triglyceride and FFA level in liver tissue
HFD significantly increased triglyceride and FFA by 3
and 2.8 folds when compared with normal chow fed
rats. The optimal dose matched group, the chlorogenic
acid group, and the gardenia glycosides group all signif-
icantly reduced the elevated levels of triglyceride and
FFA induced by HFD, compared to the model group
(Table 5).
Serum ALT and AST activity in serum
Compared with the control group (24.4 ± 5.6) and
(25.8 ± 3.9) U/L, serum ALT and AST activity in the
model group significantly increased (72.1 ± 12.6) and
(70.4±14.8) U/L (P < 0.01), and compared with the
model group, serum ALT, AST activities in the treat-
ment groups significantly decreased (P < 0.05, P <
0.01).
Liver tissue MDA and SOD activity
Compared with the control group, liver MDA activity
in the model group significantly increased while SOD
activity decreased (P < 0.01); compared with the mod-
el group, the treatment group has function to improve
the changes (P < 0.05, P < 0.01).
Pathological changes in hepatic tissue
The photomicrographs of the HE stain showed that
HFD increased hepatic fat deposit, evidenced by the
majority of the hepatocytes of HFD rats distended by
fat in comparison to the control group (Figures 1A,
1B). The images of HE staining also displayed mac-
rovesicular steatosis for many single large droplets had
displaced the nucleus and ballooning degeneration
caused conspicuous swelling of the cell and cytoplas-
mic vacuolation (Figure 1B). In the decoction group
and the solution group, lipid degeneration and inflam-
matory response were significantly alleviated compared
with the model group. Liver cell volume became small-
er, hepatic lobules were clearly delineated, and the fat
droplets were reduced (Figure 1C-1E).
DISCUSSION
NAFLD is a kind of metabolic stress liver injury,
which is closely related to insulin resistance and genetic
susceptibility. In recent years, the global epidemiologi-
cal survey shows that NAFLD is the most common liv-
er disease in the world, and its prevalence in developed
countries is 30%, the prevalence of the disease in devel-
oping countries is also close to 10% .8 Modern medi-
cine, however, has not found a specific effective drug
for NAFLD.9 It has confirmed that TCM is one of the
major treatment for NAFLD in China. However, it is
difficult for TCM to be widely accepted because of the
scientific problems "the material basis and effective
components of TCM is not clear".10 With the develop-
ment of TCM, scholars have generally accepted that
the effective components of TCM were important for
TCM compound to treat disease.11,12
Table 4 Comparison of body weight, liver wet weight and fat
weight of all groups (g, xˉ ± s)
Group
Control
Model
1
2
3
n
10
10
10
10
10
Body weight
332.0±24.0
435.0±39.0a
353.0±13.0c
392.0±25.0bd
385.0±29.0bd
Liver weight
8.4±0.7
17.5±0.8a
14.3±0.7c
15.5±0.5b
15.6±0.5c
Fat weight
6.4±0.5
10.5±1.3a
7.1±1.0c
8.9±0.8bd
7.6±0.8b
Notes: The control group was fed with regular diet, the model
group induced by high fat feed (HFD) for 8 weeks. Group 1
was the optimal dose matched group, which was induced by
HFD and treated with 90 mg·kg－ 1·d－ 1 Chlorogenic acid and
90 mg·kg－1·d－1 Gardenia glycosides. Group 2 was induced by
HFD and treated with 90 mg·kg－1·d－1 Chlorogenic acid, while
group 3 was induced by HFD and treated with 90 mg·kg－1·d－1
chlorogenic acid. Group 1, group 2 and group 3 all were intra-
gastrically administered once a day for 4 weeks from the begin-
ning of the fifth week to the end of eighth week. The control
group and model group were intragastrically administered an
equal volume of drinking water at the same time. Compared
with the control group, a P < 0.01; compared with the model
group, bP < 0.05, cP < 0.01; compared with the optimal dose
matched group, dP < 0.05.
Table 3 Uniform design regression equation with different
indexes
Regression equation
YTG =128-252X1X2
YFFA=601-2438 X1X2
YALT=145-265X1X2
YAST=167-972X1X2
YMDA=58-234X1X2
YSOD=86+641X1X2
r value
0.983
0.921
0.912
0.877
0.862
0.932
P value
0.000
0.003
0.006
0.012
0.021
0.014
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"Uniform design method" is a combination of number
theory and multivariate statistical method for experi-
mental design used in the experimental study of multi-
ple factors and levels. At present, the uniform design
method has been gradually applied to the study of
TCM, it could be used to screen material basis or effec-
tive components of TCM compound,13-15 and the reli-
ability of its screening has been preliminarily verified.
The method is used to simplify the experimental opera-
tion, reduce the number of experiments, quantitatively
analyze the influence of various factors on the test re-
sults, and quantitatively predict the interval estimation
of the optimal conditions and the optimization results.
Uniform design method has the advantage of fully us-
ing multiple factors and levels to analyze components
of TCM compound and give quantitative prediction of
the condition of compound dosage optimization.
Based on our findings, it can be concluded that chloro-
genic acid of 90 mg plus gardenia glycosides of 90 mg
was the best combination in the treatment of fatty liver
disease in rats induced by high-fat diet.
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